Eurofins Scientific SE (ERF.PA)
EUR 56.58
(1.98%)
EUR 56.58
(1.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.88 Billion EUR | 7.98% |
| 2022 | 10.08 Billion EUR | 8.05% |
| 2021 | 9.33 Billion EUR | 8.83% |
| 2020 | 8.57 Billion EUR | 9.62% |
| 2019 | 7.82 Billion EUR | 8.57% |
| 2018 | 7.2 Billion EUR | 23.54% |
| 2017 | 5.83 Billion EUR | 41.24% |
| 2016 | 4.12 Billion EUR | 11.61% |
| 2015 | 3.69 Billion EUR | 97.52% |
| 2014 | 1.87 Billion EUR | 25.13% |
| 2013 | 1.49 Billion EUR | 29.15% |
| 2012 | 1.15 Billion EUR | 7.87% |
| 2011 | 1.07 Billion EUR | 45.97% |
| 2010 | 736.16 Million EUR | 11.66% |
| 2009 | 659.29 Million EUR | -10.18% |
| 2008 | 734.01 Million EUR | 19.93% |
| 2007 | 612.02 Million EUR | 32.95% |
| 2006 | 460.33 Million EUR | 72.95% |
| 2005 | 266.16 Million EUR | 39.99% |
| 2004 | 190.12 Million EUR | 14.2% |
| 2003 | 166.48 Million EUR | 3.88% |
| 2002 | 160.26 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 10.79 Billion EUR | -0.84% |
| 2024 Q2 | 10.79 Billion EUR | 0.0% |
| 2023 Q2 | 10.31 Billion EUR | 0.0% |
| 2023 Q3 | 10.88 Billion EUR | 5.53% |
| 2023 FY | 10.88 Billion EUR | 7.98% |
| 2023 Q4 | 10.88 Billion EUR | 0.0% |
| 2023 Q1 | 10.31 Billion EUR | 2.32% |
| 2022 Q2 | 10.26 Billion EUR | 0.0% |
| 2022 Q1 | 10.26 Billion EUR | 9.95% |
| 2022 FY | 10.08 Billion EUR | 8.05% |
| 2022 Q4 | 10.08 Billion EUR | 0.0% |
| 2022 Q3 | 10.08 Billion EUR | -1.73% |
| 2021 Q4 | 9.33 Billion EUR | 0.0% |
| 2021 Q3 | 9.33 Billion EUR | 7.75% |
| 2021 FY | 9.33 Billion EUR | 8.83% |
| 2021 Q2 | 8.66 Billion EUR | 0.0% |
| 2021 Q1 | 8.66 Billion EUR | 1.0% |
| 2020 Q4 | 8.57 Billion EUR | 0.0% |
| 2020 Q3 | 8.57 Billion EUR | 6.03% |
| 2020 FY | 8.57 Billion EUR | 9.62% |
| 2020 Q1 | 8.08 Billion EUR | 3.39% |
| 2020 Q2 | 8.08 Billion EUR | 0.0% |
| 2019 Q2 | 7.68 Billion EUR | 0.0% |
| 2019 Q3 | 7.82 Billion EUR | 1.75% |
| 2019 Q1 | 7.68 Billion EUR | 6.7% |
| 2019 FY | 7.82 Billion EUR | 8.57% |
| 2019 Q4 | 7.82 Billion EUR | 0.0% |
| 2018 Q4 | 7.2 Billion EUR | 0.0% |
| 2018 FY | 7.2 Billion EUR | 23.54% |
| 2018 Q1 | 5.94 Billion EUR | 1.89% |
| 2018 Q2 | 5.94 Billion EUR | 0.0% |
| 2018 Q3 | 7.2 Billion EUR | 21.26% |
| 2017 Q4 | 5.83 Billion EUR | 0.0% |
| 2017 Q3 | 5.83 Billion EUR | 45.31% |
| 2017 Q2 | 4.01 Billion EUR | 0.0% |
| 2017 FY | 5.83 Billion EUR | 41.24% |
| 2017 Q1 | 4.01 Billion EUR | -2.8% |
| 2016 Q4 | 4.12 Billion EUR | 0.0% |
| 2016 Q2 | 3.84 Billion EUR | 0.0% |
| 2016 Q1 | 3.84 Billion EUR | 4.01% |
| 2016 FY | 4.12 Billion EUR | 11.61% |
| 2016 Q3 | 4.12 Billion EUR | 7.31% |
| 2015 FY | 3.69 Billion EUR | 97.52% |
| 2015 Q4 | 3.69 Billion EUR | 0.0% |
| 2015 Q3 | 3.69 Billion EUR | 30.8% |
| 2015 Q2 | 2.82 Billion EUR | 0.0% |
| 2015 Q1 | 2.82 Billion EUR | 51.0% |
| 2014 Q2 | 1.69 Billion EUR | 0.0% |
| 2014 Q3 | 1.87 Billion EUR | 10.32% |
| 2014 Q4 | 1.87 Billion EUR | 0.0% |
| 2014 FY | 1.87 Billion EUR | 25.13% |
| 2014 Q1 | 1.69 Billion EUR | 13.42% |
| 2013 Q1 | 1.23 Billion EUR | 6.27% |
| 2013 Q2 | 1.23 Billion EUR | 0.0% |
| 2013 Q4 | 1.49 Billion EUR | 0.0% |
| 2013 Q3 | 1.49 Billion EUR | 21.53% |
| 2013 FY | 1.49 Billion EUR | 29.15% |
| 2012 Q2 | 1.09 Billion EUR | 276.67% |
| 2012 FY | 1.15 Billion EUR | 7.87% |
| 2012 Q3 | 1.16 Billion EUR | 6.33% |
| 2012 Q4 | 1.15 Billion EUR | -0.12% |
| 2012 Q1 | 289.77 Million EUR | -73.03% |
| 2011 Q3 | 961.26 Million EUR | 11.55% |
| 2011 Q1 | 858.22 Million EUR | 16.58% |
| 2011 Q2 | 861.72 Million EUR | 0.41% |
| 2011 Q4 | 1.07 Billion EUR | 11.79% |
| 2011 FY | 1.07 Billion EUR | 45.97% |
| 2010 Q2 | 783.73 Million EUR | 21.17% |
| 2010 FY | 736.16 Million EUR | 11.66% |
| 2010 Q3 | 739.52 Million EUR | -5.64% |
| 2010 Q4 | 736.16 Million EUR | -0.46% |
| 2010 Q1 | 646.82 Million EUR | -1.89% |
| 2009 FY | 659.29 Million EUR | -10.18% |
| 2009 Q4 | 659.29 Million EUR | 300.0% |
| 2009 Q2 | 164.82 Million EUR | 0.0% |
| 2009 Q1 | 164.82 Million EUR | -10.18% |
| 2009 Q3 | 164.82 Million EUR | 0.0% |
| 2008 Q4 | 183.5 Million EUR | 0.0% |
| 2008 Q1 | 183.5 Million EUR | 19.93% |
| 2008 Q3 | 183.5 Million EUR | 0.0% |
| 2008 FY | 734.01 Million EUR | 19.93% |
| 2008 Q2 | 183.5 Million EUR | 0.0% |
| 2007 Q3 | 153 Million EUR | 0.0% |
| 2007 Q2 | 153 Million EUR | 0.0% |
| 2007 Q4 | 153 Million EUR | 0.0% |
| 2007 Q1 | 153 Million EUR | 32.95% |
| 2007 FY | 612.02 Million EUR | 32.95% |
| 2006 Q4 | 115.08 Million EUR | 0.0% |
| 2006 Q3 | 115.08 Million EUR | 0.0% |
| 2006 Q2 | 115.08 Million EUR | 0.0% |
| 2006 FY | 460.33 Million EUR | 72.95% |
| 2006 Q1 | 115.08 Million EUR | 72.95% |
| 2005 Q4 | 66.54 Million EUR | 0.0% |
| 2005 Q3 | 66.54 Million EUR | 0.0% |
| 2005 Q2 | 66.54 Million EUR | 0.0% |
| 2005 Q1 | 66.54 Million EUR | 39.99% |
| 2005 FY | 266.16 Million EUR | 39.99% |
| 2004 Q3 | 47.53 Million EUR | 0.0% |
| 2004 Q4 | 47.53 Million EUR | 0.0% |
| 2004 Q2 | 47.53 Million EUR | 0.0% |
| 2004 Q1 | 47.53 Million EUR | 14.2% |
| 2004 FY | 190.12 Million EUR | 14.2% |
| 2003 Q3 | 41.62 Million EUR | 0.0% |
| 2003 Q4 | 41.62 Million EUR | 0.0% |
| 2003 FY | 166.48 Million EUR | 3.88% |
| 2003 Q2 | 41.62 Million EUR | 0.0% |
| 2003 Q1 | 41.62 Million EUR | 3.88% |
| 2002 Q1 | 40.06 Million EUR | 0.0% |
| 2002 Q4 | 40.06 Million EUR | 0.0% |
| 2002 FY | 160.26 Million EUR | 0.0% |
| 2002 Q3 | 40.06 Million EUR | 0.0% |
| 2002 Q2 | 40.06 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biosynex SA | 241.72 Million EUR | -4404.466% |
| Predilife S.A. | 8.81 Million EUR | -123374.906% |
| bioMérieux S.A. | 5.25 Billion EUR | -107.039% |
| Lumibird SA | 405.24 Million EUR | -2586.898% |